C. Ola Landgren, Leader of Translational and Clinical Oncology Program Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“Thanks SWOG Cancer Research Network (SWOG) and Chair Dr. Amrita Krishnan from City of Hope, for inviting me to be the Keynote Speaker at the Barlogie Salmon Myeloma session at the SWOG fall meeting today in Chicago.
I was speaking on the topic, ‘From Population Averages to Individual Futures: AI in Myeloma Research and Clinical Trials.’
It was wonderful to interact with myeloma experts from all over the United States.
Our Sylvester Myeloma Institute, located at Sylvester Comprehensive Cancer Center, University of Miami, had a great representation at the SWOG meeting today.
It was fun to listen to Dickran Kazandjian, who spoke about future opportunities in myeloma drug development, and to discuss basic science and translational research with Dr. Brian Walker.”
You can also read:
SWOG/NRG S1914 Trial: Does Immunotherapy Add Benefit to SBRT in Early-Stage NSCLC?
